hepatology
美 [hepə'tɒlədʒɪ] 
英 [hepə'tɒlədʒɪ]
英汉解释
例句
HEPATOLOGY DIGEST: Right, so through these integrative efforts we might be able to control the progression of liver cancer, right?
《国际肝病》：那么是不是通过这些综合治疗手段我们就可能控制肝癌的进展？
Hepatology Digest: Thank you both. It was a pleasure and I hope to see you next year.
国际肝病：感谢二位，非常高兴，希望明年再次见面。
Hepatology Digest: The last thing I would like to ask you about is sorafenib .
国际肝病：最后我想问的是索拉非尼。
Hepatology Digest: how do you think the clinical practice of proteinase inhibitors ? Will the side effects affect its clinical use?
《国际肝病》：您怎样看待蛋白酶抑制剂在临床上的应用以及这些药物的副作用？
Hepatology Digest: The liver is known as an immunologically privileged organ in solid organ transplants.
《国际肝病》：在实体器官移植中，肝脏被称为免疫特惠器官。
Hepatology Digest: From your experience, RFA is an efficient treatment for HCC. What are the indications and contraindications for RFA?
《国际肝病》：从您的经验来看，RFA是一种治疗肝细胞癌的有效方法。那么RFA的适应证和禁忌证有哪些？
Hepatology Digest: The reason I ask is that there is a bit of a mixed message here. Red wine is promoted as a good anti-oxidant for example.
《国际肝病》：之所以我这么问是有一点潜藏在这里，例如红酒被作为一种良好的抗氧化。
Hepatology Digest: Professor Jia, do you know of any similar compounds that are being researched in China?
《国际肝病》：贾教授，就您所知，是否有其他类似化合物在中国正在被研究呢？
Hepatology Digest: It seems that most people today don't recommend switching at this point and it is more of an add-on strategy.
肝病文摘：看来，大多数人今天不建议交换在这一点上，它更是一个附加的战略。
Hepatology Digest: The two approved DAA drugs, telaprevir and boceprevir, were thought of the first generation protease inhibitors.
《国际肝病》：已批准的两种DAA，telaprevir和boceprevir，是第一代蛋白酶抑制剂。
Hepatology Digest: For the treatment of chronic hepatitis B patients with cirrhosis what are the issues required for special intervention?
《国际肝病》：对于合并肝硬化的慢性乙型肝炎患者，我们需要特别注意什么？
Hepatology Digest : Could you tell us your opinion on the current state of affairs in the diagnosis of this pathology?
《国际肝病》：您是否能谈谈您在目前肝肺综合征诊断方面的观点？
Hepatology Digest: Amniotic fluid is said to contain a wide variety of useful cells. Could you comment about obtaining cells in this manner?
《国际肝病》：羊水里含有多种有价值的干细胞，能否请您就这种获取干细胞的方式做一评论？
Hepatology Digest: In the rest of the world, could you give us an update on how the hepatitis B vaccine is being applied?
《国际肝病》：您能谈一下世界其他地区乙肝疫苗接种的进展吗？
Hepatology Digest: When intra-uterine transmission happens, the vaccination and hepatitis B immunoglobulin might not be functional.
《国际肝病》：如果在子宫内发生了传染，可能疫苗和乙肝免疫球蛋白就会不起作用了。
Hepatology Digest: At present, interventional therapy is still the more effective treatment strategy for unresectable HCC patients.
国际肝病：对于无法手术切除的肝癌病人，介入治疗仍是目前较有效的治疗方法。
Department of Gastroenterology and Hepatology, National University Health System, Singapore, Singapore.
胃肠病学和肝病学系，新加坡，新加坡国立大学卫生系统。
Hepatology Digest: What are the differences between antiviral treatment in pre-transplant and post-transplant in HBV patients?
肝病文摘：之间有什么区别抗病毒治疗在移植前和移植后的HBV患者？
Hepatology Digest : Could you provide us an outline on the latest advancements on improving the management of this pathology?
《国际肝病》：您能否大概谈下目前肝肺综合征治疗方面的新进展？
Hepatology Digest: What advances in pharmacological treatment can halt progression to decompensated cirrhosis or reverse cirrhosis?
《国际肝病》：目前对于阻止失代偿肝硬化进展或逆转肝硬化有哪些药物治疗进展？
Hepatology Digest: There is now no effective treatment for Wilson's disease related liver cirrhosis besides liver transplantation.
国际肝病：除了肝移植外，目前还没有有效治疗Wilson病相关肝硬化的方法。
Hepatology Digest: You mentioned one of the hot topics is the direct antivirals.
《国际肝病》：您提到最热门的话题是直接抗病毒药物治疗。
Hepatology Digest: Individualized treatment is important for chronic hepatitis C using current available direct acting antivirals (DAA).
《国际肝病》：慢性丙型肝炎应用当前有效的DAA治疗，个体化治疗很重要。
Hepatology Digest: Can pre-transplantation antiviral treatment improve the post-transplantation survival rate?
《国际肝病》：请问移植前抗病毒治疗能改善移植后生存率吗？
Dept of Gastroenterology and Hepatology, National University Health System, Singapore, Singapore.
胃肠病学和肝病学系，新加坡，新加坡国立大学健康系统。
Hepatology Digest: Following up on that: you mentioned that in 2008 the pathogenesis of non-alcoholic steatohepatitis is not necessary know.
国际肝病：您提到非酒精性脂肪性肝炎的发病机制还不完全清楚。
Hepatology Digest : This year you conducted a prospective population-based surveillance to estimate newly diagnosed CLD incidence.
《国际肝病》：您今年开展了一项基于人群的前瞻性监测研究，以评估新近诊断的慢性肝病患病率。
Hepatology Digest: Do you think HCC is a major indication for living donor transplantation? Why or why not?
《国际肝病》：您认为HCC可以作为活体供肝肝移植的一个主要适应证吗？为什么？
Hepatology Digest: What would be your experience and approach Professor Xie?
《国际肝病》：谢教授您的经验呢？
Hepatology Digest: In the guideline, non-invasive markers may be used to measure liver disease.
《国际肝病》：指南中，非侵入性标记物可被用于评估肝病。
Hepatology Digest: What are the potential mechanisms of HBsAg seroconversion?
《国际肝病》：HBsAg血清学转换发生的可能机制是什么？
Hepatology Digest: You should probably define moderate at this point. What is moderate?
《国际肝病》：在这时候你或许应该定义一下适度，什么是适度？。
Division of Hepatology, California Pacific Medical Center and ResearchInstitute, San Francisco, CA, United States.
肝脏，加州太平洋医疗中心研究所，旧金山，加利福尼亚，美国司。
Hepatology Digest: At present, several clinical studies of direct acting antivirals (DAA) combinations are ongoing.
《国际肝病》：目前，几项有关直接作用抗病毒药物（DAA）联合治疗的临床研究正在进行。
HEPATOLOGY DIGEST: How do you think about the current and emerging therapies on hepatocellular cancer?
《国际肝病》：您是如何看待目前有关肝细胞肝癌的治疗进展的？
Severe Liver Diseases and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association.
中华医学会肝病学分会重型肝病与人工肝学组。
Hepatology Digest: Both host and viral factors are involved in chronic HCV infection, and escape from innate and adaptive immune responses.
《国际肝病》：宿主和病毒因素都参与了慢性HCV感染以及固有和适应性免疫应答逃避。
The findings appear in the April issue of Hepatology, a journal of the American Association for the Study of Liver Diseases (AASLD).
这一发现刊登在美国肝病研究协会（AASLD）的杂志《肝脏病学》四月刊。
Hepatology Digest: There's a slight difference at the end of treatment numbers I believe, right?
国际肝病：在治疗的最终结果上还是稍有不同的，对么？
Hepatology Digest: You mentioned that there distinct differences of CD8 T cells in HCV patients . Can you please elaborate on this?
《国际肝病》：您曾提到，丙型肝炎患者之间的CD8+T细胞存在明显区别。您能详细解释一下吗？
